nach oben

Erschienen in:

05.08.2017 | Original Article

Molecular analysis of more than 140 gene fusion variants and aberrant activation of EVI1 and TLX1 in hematological malignancies

verfasst von: Faramarz Ghasemian Sorbeni, Soheila Montazersaheb, Atefeh Ansarin, Ali Esfahani, Azim Rezamand, Ebrahim Sakhinia

Erschienen in: Annals of Hematology | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Gene fusions are observed in abnormal chromosomal rearrangements such as translocations in hematopoietic malignancies, especially leukemia subtypes. Hence, it is critical to obtain correct information about these rearrangements in order to apply proper treatment techniques. To identify abnormal molecular changes in patients with leukemia, we developed a multiplex reverse transcriptase polymerase chain reaction (MRT-PCR) protocol and investigated more than 140 gene fusions resulting from variations of 29 prevalent chromosomal rearrangements along with EVI1 and TLX1 oncogenic expression in the presence of optimized primers. The potential of the MRT-PCR method was approved by evaluating the available cell lines as positive control and confirmed by sequencing. Samples from 53 patients afflicted with hematopoiesis malignancies were analyzed. Results revealed at least one chromosomal rearrangement in 69% of acute myeloid leukemia subjects, 64% of acute lymphoblastic leukemia subjects, and 81% of chronic myeloid leukemia subjects, as well as a subject with hypereosinophilic syndrome. Also, five novel fusion variants were detected. Results of this study also showed that chromosomal rearrangements, both alone and in conjunction with other rearrangements, are involved in leukemogenesis. Moreover, it was found that EVI1 is a suitable hallmark for hematopoietic malignancies.

Bacolla A, Tainer JA, Vasquez KM, Cooper DN (2016) Translocation and deletion breakpoints in cancer genomes are associated with potential non-B DNA-forming sequences. Nucleic Acids Res 44(12):5673–5688. doi:10.1093/nar/gkw261 PubMedPubMedCentralCrossRef

Nambiar M, Raghavan SC (2011) How does DNA break during chromosomal translocations? Nucleic Acids Res 39(14):5813–5825. doi:10.1093/nar/gkr223 PubMedPubMedCentralCrossRef

Pallisgaard N, Hokland P, Riishoj DC, Pedersen B, Jorgensen P (1998) Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood 92(2):574–588PubMed

Liu PP, Hajra A, Wijmenga C, Collins FS (1995) Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 85(9):2289–2302PubMed

Pandolfi PP, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D, Biondi A, Lo Coco F, Rambaldi A, Grignani F et al (1992) Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia. EMBO J 11(4):1397–1407PubMedPubMedCentral

Meyer-Monard S, Parlier V, Passweg J, Muhlematter D, Hess U, Bargetzi M, Kuhne T, Cabrol C, Gratwohl A, Jotterand M, Tichelli A (2006) Combination of broad molecular screening and cytogenetic analysis for genetic risk assignment and diagnosis in patients with acute leukemia. Leukemia 20(2):247–253. doi:10.1038/sj.leu.2404044 PubMedCrossRef

Bonomi R, Giordano H, del Pilar MM, Bodega E, Landoni AI, Gallagher R, del Rosario UM (2000) Simultaneous PML/RARalpha and AML1/ETO expression with t(15;17) at onset and relapse with only t(8;21) in an acute promyelocytic leukemia patient. Cancer Genet Cytogenet 123(1):41–43PubMedCrossRef

Berger R, Bernheim A, Daniel MT, Flandrin G (1983) t(15;17) in a promyelocytic form of chronic myeloid leukemia blastic crisis. Cancer Genet Cytogenet 8(2):149–152PubMedCrossRef

Licht JD (2001) AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML. Oncogene 20(40):5660–5679. doi:10.1038/sj.onc.1204593 PubMedCrossRef

10.

Elia L, Mancini M, Moleti L, Meloni G, Buffolino S, Krampera M, De Rossi G, Foa R, Cimino G (2003) A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia. Haematologica 88(3):275–279PubMed

11.

Geng Z, Zhang H, Wang D, Xiao Y, Wang N, Li C, Huang L, Zhou J (2012) Combination of cytogenetic analysis and molecular screening in patients with de novo acute myeloid leukemia. J Huazhong Univ Sci Technolog Med Sci 32(4):501–510. doi:10.1007/s11596-012-0087-6 PubMedCrossRef

12.

Pruett SB, Obiri N, Kiel JL (1989) Involvement and relative importance of at least two distinct mechanisms in the effects of 2-mercaptoethanol on murine lymphocytes in culture. J Cell Physiol 141(1):40–45. doi:10.1002/jcp.1041410107 PubMedCrossRef

13.

De Weer A, Poppe B, Cauwelier B, Van Roy N, Dastugue N, Hagemeijer A, De Paepe A, Speleman F (2006) Screening for EVI1: ectopic expression absent in T-cell acute lymphoblastic leukemia patients and cell lines. Cancer Genet Cytogenet 171(1):79–80. doi:10.1016/j.cancergencyto.2006.07.004 PubMedCrossRef

14.

Sato T, Goyama S, Kataoka K, Nasu R, Tsuruta-Kishino T, Kagoya Y, Nukina A, Kumagai K, Kubota N, Nakagawa M, Arai S, Yoshimi A, Honda H, Kadowaki T, Kurokawa M (2014) Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia. Oncogene 33(42):5028–5038. doi:10.1038/onc.2014.108 PubMedPubMedCentralCrossRef

15.

Raza A, Buonamici S, Lisak L, Tahir S, Li D, Imran M, Chaudary NI, Pervaiz H, Gallegos JA, Alvi MI, Mumtaz M, Gezer S, Venugopal P, Reddy P, Galili N, Candoni A, Singer J, Nucifora G (2004) Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression. Leuk Res 28(8):791–803. doi:10.1016/j.leukres.2003.11.018 PubMedCrossRef

16.

Smol T, Nibourel O, Marceau-Renaut A, Celli-Lebras K, Berthon C, Quesnel B, Boissel N, Terre C, Thomas X, Castaigne S, Dombret H, Preudhomme C, Renneville A (2015) Quantification of EVI1 transcript levels in acute myeloid leukemia by RT-qPCR analysis: a study by the ALFA Group. Leuk Res 39(12):1443–1447. doi:10.1016/j.leukres.2015.09.021 PubMedCrossRef

17.

Stevens A, Hanson D, de Leonibus C, Whatmore A, Donn R, White DJ, Liu J, van den Heuvel-Eibrink MM, Saha V, Clayton PE, Meyer S (2014) EVI1 expression in childhood acute lymphoblastic leukaemia is not restricted to MLL and BCR/ABL rearrangements and is influenced by age. Blood Cancer J 4:e179. doi:10.1038/bcj.2013.76 PubMedPubMedCentralCrossRef

18.

Kennedy MA, Gonzalez-Sarmiento R, Kees UR, Lampert F, Dear N, Boehm T, Rabbitts TH (1991) HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. Proc Natl Acad Sci U S A 88(20):8900–8904PubMedPubMedCentralCrossRef

19.

Aplan PD, Lombardi DP, Ginsberg AM, Cossman J, Bertness VL, Kirsch IR (1990) Disruption of the human SCL locus by “illegitimate” V-(D)-J recombinase activity. Science 250(4986):1426–1429PubMedCrossRef

20.

Caligiuri MA, Strout MP, Schichman SA, Mrozek K, Arthur DC, Herzig GP, Baer MR, Schiffer CA, Heinonen K, Knuutila S, Nousiainen T, Ruutu T, Block AW, Schulman P, Pedersen-Bjergaard J, Croce CM, Bloomfield CD (1996) Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res 56(6):1418–1425PubMed

21.

Poirel H, Rack K, Delabesse E, Radford-Weiss I, Troussard X, Debert C, Leboeuf D, Bastard C, Picard F, Veil-Buzyn A, Flandrin G, Bernard O, Macintyre E (1996) Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5. Blood 87(6):2496–2505PubMed

22.

van der Reijden BA, Dauwerse HG, Giles RH, Jagmohan-Changur S, Wijmenga C, Liu PP, Smit B, Wessels HW, Beverstock GC, Jotterand-Bellomo M, Martinet D, Muhlematter D, Lafage-Pochitaloff M, Gabert J, Reiffers J, Bilhou-Nabera C, van Ommen GJ, Hagemeijer A, Breuning MH (1999) Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered. Oncogene 18(2):543–550. doi:10.1038/sj.onc.1202321 PubMedCrossRef

23.

Stulberg J, Kamel-Reid S, Chun K, Tokunaga J, Wells RA (2002) Molecular analysis of a new variant of the CBF beta-MYH11 gene fusion. Leuk Lymphoma 43(10):2021–2026. doi:10.1080/1042819021000015989-1 PubMedCrossRef

24.

Rowe D, Strain L, Lowe C, Jones G (2007) A case of acute myeloid leukemia with inv(16)(p13q22) reveals a novel MYH11 breakpoint and a new CBF beta-MYH11 transcript variant. Haematologica 92(10):1433–1434. doi:10.3324/haematol.11536 PubMedCrossRef

25.

Borkhardt A, Repp R, Haas OA, Leis T, Harbott J, Kreuder J, Hammermann J, Henn T, Lampert F (1997) Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23). Oncogene 14(2):195–202. doi:10.1038/sj.onc.1200814 PubMedCrossRef

26.

Tse W, Zhu W, Chen HS, Cohen A (1995) A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells. Blood 85(3):650–656PubMed

27.

Busson-Le Coniat M, Salomon-Nguyen F, Hillion J, Bernard OA, Berger R (1999) MLL-AF1q fusion resulting from t(1;11) in acute leukemia. Leukemia 13(2):302–306PubMedCrossRef

28.

Lee SG, Park TS, Yang JJ, Oh SH, Cho EH, Lee S, Oh D, Huh JY, Marschalek R, Meyer C (2012) Molecular identification of a new splicing variant of the MLL - MLLT11 fusion transcript in an adult with acute myeloid leukemia and t(1;11)(q21;q23). Acta Haematol 128(3):131–138. doi:10.1159/000338258 PubMedCrossRef

29.

Sagawa M, Shimizu T, Shimizu T, Awaya N, Mitsuhashi T, Ikeda Y, Okamoto S, Kizaki M (2006) Establishment of a new human acute monocytic leukemia cell line TZ-1 with t(1;11)(p32;q23) and fusion gene MLL-EPS15. Leukemia 20(9):1566–1571. doi:10.1038/sj.leu.2404305 PubMedCrossRef

30.

Bernard OA, Mauchauffe M, Mecucci C, Van den Berghe H, Berger R (1994) A novel gene, AF-1p, fused to HRX in t(1;11)(p32;q23), is not related to AF-4, AF-9 nor ENL. Oncogene 9(4):1039–1045PubMed

31.

Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD, Cleary ML (1990) Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60(4):535–545PubMedCrossRef

32.

Izraeli S, Kovar H, Gadner H, Lion T (1992) Unexpected heterogeneity in E2A/PBX1 fusion messenger RNA detected by the polymerase chain reaction in pediatric patients with acute lymphoblastic leukemia. Blood 80(6):1413–1417PubMed

33.

Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT (1994) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263(5151):1281–1284PubMedCrossRef

34.

Trumper L, Daus H, Merz H, von Bonin F, Loftin U, Cochlovius C, Moller P, Feller AC, Pfreundschuh M (1997) NPM/ALK fusion mRNA expression in Hodgkin and Reed-Sternberg cells is rare but does occur: results from single-cell cDNA analysis. Ann Oncol 8(Suppl 2):83–87PubMedCrossRef

35.

Weisenburger DD, Gordon BG, Vose JM, Bast MA, Chan WC, Greiner TC, Anderson JR, Sanger WG (1996) Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma. Blood 87(9):3860–3868PubMed

36.

Yoneda-Kato N, Look AT, Kirstein MN, Valentine MB, Raimondi SC, Cohen KJ, Carroll AJ, Morris SW (1996) The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene 12(2):265–275PubMed

37.

Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H (1994) Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J 13(3):504–510PubMedPubMedCentral

38.

Nucifora G, Begy CR, Kobayashi H, Roulston D, Claxton D, Pedersen-Bjergaard J, Parganas E, Ihle JN, Rowley JD (1994) Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc Natl Acad Sci U S A 91(9):4004–4008PubMedPubMedCentralCrossRef

39.

Yamamoto K, Seto M, Iida S, Komatsu H, Kamada N, Kojima S, Kodera Y, Nakazawa S, Saito H, Takahashi T et al (1994) A reverse transcriptase-polymerase chain reaction detects heterogeneous chimeric mRNAs in leukemias with 11q23 abnormalities. Blood 83(10):2912–2921PubMed

40.

Downing JR, Head DR, Raimondi SC, Carroll AJ, Curcio-Brint AM, Motroni TA, Hulshof MG, Pullen DJ, Domer PH (1994) The der(11)-encoded MLL/AF-4 fusion transcript is consistently detected in t(4;11)(q21;q23)-containing acute lymphoblastic leukemia. Blood 83(2):330–335PubMed

41.

Ivanov IC, Jitaru D, Grigore GE, Zlei M, Ivanov AV, Dumitras S, Carasevici E, Miron IC (2013) Infant acute leukemia with lineage switch at relapse expressing a novel t(4;11)(q21;q23) MLL-AF4 fusion transcript. Revista Româd de Medicin de Laborator 21:47–58. doi:10.2478/rrlm-2013-0017

42.

Corral J, Forster A, Thompson S, Lampert F, Kaneko Y, Slater R, Kroes WG, van der Schoot CE, Ludwig WD, Karpas A et al (1993) Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Proc Natl Acad Sci U S A 90(18):8538–8542PubMedPubMedCentralCrossRef

43.

Abdelhaleem M, Yi Q, Beimnet K, Grant R (2007) A novel t(4;11)(q21;q23) MLL-AF4 fusion transcript in infant leukemia. Am J Hematol 82(3):247. doi:10.1002/ajh.20731 PubMedCrossRef

44.

Curtis CE, Grand FH, Waghorn K, Sahoo TP, George J, Cross NC (2007) A novel ETV6-PDGFRB fusion transcript missed by standard screening in a patient with an imatinib responsive chronic myeloproliferative disease. Leukemia 21(8):1839–1841. doi:10.1038/sj.leu.2404728 PubMedCrossRef

45.

Golub TR, Barker GF, Lovett M, Gilliland DG (1994) Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77(2):307–316PubMedCrossRef

46.

Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ (1996) The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood 87(3):882–886PubMed

47.

Hamaguchi H, Nagata K, Yamamoto K, Fujikawa I, Kobayashi M, Eguchi M (1998) Establishment of a novel human myeloid leukaemia cell line (FKH-1) with t(6;9)(p23;q34) and the expression of dek-can chimaeric transcript. Br J Haematol 102(5):1249–1256PubMedCrossRef

48.

Chen S, Xue Y, Zhang X, Wu Y, Pan J, Wang Y, Ceng J (2005) A new human acute monocytic leukemia cell line SHI-1 with t(6;11)(q27;q23), p53 gene alterations and high tumorigenicity in nude mice. Haematologica 90(6):766–775PubMed

49.

Kakuda H, Sato T, Hayashi Y, Enomoto Y, Takayama J, Ohira M, Seto M, Ueda R, Fuse A, Niimi H (1996) A novel human leukaemic cell line, CTS, has a t(6;11) chromosomal translocation and characteristics of pluripotent stem cells. Br J Haematol 95(2):306–318PubMedCrossRef

50.

Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y, Kamada N, Ohki M (1993) The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J 12(7):2715–2721PubMedPubMedCentral

51.

Matozaki S, Nakagawa T, Kawaguchi R, Aozaki R, Tsutsumi M, Murayama T, Koizumi T, Nishimura R, Isobe T, Chihara K (1995) Establishment of a myeloid leukaemic cell line (SKNO-1) from a patient with t(8;21) who acquired monosomy 17 during disease progression. Br J Haematol 89(4):805–811PubMedCrossRef

52.

Quentmeier H, Schneider B, Rohrs S, Romani J, Zaborski M, Macleod RA, Drexler HG (2009) SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines. J Hematol Oncol 2:3. doi:10.1186/1756-8722-2-3 PubMedPubMedCentralCrossRef

53.

Van Vlierberghe P, van Grotel M, Tchinda J, Lee C, Beverloo HB, van der Spek PJ, Stubbs A, Cools J, Nagata K, Fornerod M, Buijs-Gladdines J, Horstmann M, van Wering ER, Soulier J, Pieters R, Meijerink JP (2008) The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. Blood 111(9):4668–4680. doi:10.1182/blood-2007-09-111872 PubMedPubMedCentralCrossRef

54.

Rosati R, La Starza R, Barba G, Gorello P, Pierini V, Matteucci C, Roti G, Crescenzi B, Aloisi T, Aversa F, Martelli MF, Mecucci C (2007) Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemia. Haematologica 92(2):232–235PubMedCrossRef

55.

Pession A, Martino V, Tonelli R, Beltramini C, Locatelli F, Biserni G, Franzoni M, Freccero F, Montemurro L, Pattacini L, Paolucci G (2003) MLL-AF9 oncogene expression affects cell growth but not terminal differentiation and is downregulated during monocyte-macrophage maturation in AML-M5 THP-1 cells. Oncogene 22(54):8671–8676. doi:10.1038/sj.onc.1207125 PubMedCrossRef

56.

Montemurro L, Tonelli R, Fazzina R, Martino V, Marino F, Pession A (2004) Identification of two MLL-MLLT3 (alias MLL-AF9) chimeric transcripts in the MOLM-13 cell line. Cancer Genet Cytogenet 154(1):96–97. doi:10.1016/j.cancergencyto.2004.01.029 PubMedCrossRef

57.

Alonso CN, Longo PL, Gallego MS, Medina A, Felice MS (2008) A novel AF9 breakpoint in MLL-AF9-positive acute monoblastic leukemia. Pediatr Blood Cancer 50(4):869–871. doi:10.1002/pbc.21393 PubMedCrossRef

58.

Nakamura T, Alder H, Gu Y, Prasad R, Canaani O, Kamada N, Gale RP, Lange B, Crist WM, Nowell PC et al (1993) Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc Natl Acad Sci U S A 90(10):4631–4635PubMedPubMedCentralCrossRef

59.

Mitterbauer G, Zimmer C, Fonatsch C, Haas O, Thalhammer-Scherrer R, Schwarzinger I, Kalhs P, Jaeger U, Lechner K, Mannhalter C (1999) Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR. Leukemia 13(10):1519–1524PubMedCrossRef

60.

Baeumler J, Szuhai K, Falkenburg JH, van Schie ML, Ottmann OG, Nijmeijer BA (2008) Establishment and cytogenetic characterization of a human acute lymphoblastic leukemia cell line (ALL-VG) with ETV6/ABL1 rearrangement. Cancer Genet Cytogenet 185(1):37–42. doi:10.1016/j.cancergencyto.2008.05.001 PubMedCrossRef

61.

Park J, Kim M, Lim J, Kim Y, Han K, Kim JS, Lee S, Kim HJ, Min WS (2013) Variant of ETV6/ABL1 gene is associated with leukemia phenotype. Acta Haematol 129(2):78–82. doi:10.1159/000342490 PubMedCrossRef

62.

Gancheva K, Virchis A, Howard-Reeves J, Cross NC, Brazma D, Grace C, Kotzampaltiris P, Partheniou F, Nacheva E (2013) Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature review. Mol Cytogenet 6(1):39. doi:10.1186/1755-8166-6-39 PubMedPubMedCentralCrossRef

63.

Yamamoto K, Yakushijin K, Nakamachi Y, Miyata Y, Sanada Y, Tanaka Y, Okamura A, Kawano S, Hayashi Y, Matsuoka H, Minami H (2014) Extramedullary T-lymphoid blast crisis of an ETV6/ABL1-positive myeloproliferative neoplasm with t(9;12)(q34;p13) and t(7;14)(p13;q11.2). Ann Hematol 93(8):1435–1438. doi:10.1007/s00277-013-1975-y PubMedCrossRef

64.

Matsuo Y, Drexler HG, Takeuchi M, Orita K (1999) A novel biphenotypic B-cell precursor leukemia cell line (NALM-29) carrying t(9;22)(q34;q11) established from a patient with acute leukemia. Leuk Res 23(8):731–740PubMedCrossRef

65.

Hermans A, Heisterkamp N, von Linden M, van Baal S, Meijer D, van der Plas D, Wiedemann LM, Groffen J, Bootsma D, Grosveld G (1987) Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell 51(1):33–40PubMedCrossRef

66.

Chaplin T, Bernard O, Beverloo HB, Saha V, Hagemeijer A, Berger R, Young BD (1995) The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene. Blood 86(6):2073–2076PubMed

67.

Prasad R, Leshkowitz D, Gu Y, Alder H, Nakamura T, Saito H, Huebner K, Berger R, Croce CM, Canaani E (1994) Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1 (MLL) in acute leukemia. Proc Natl Acad Sci U S A 91(17):8107–8111PubMedPubMedCentralCrossRef

68.

Strehl S, Konig M, Meyer C, Schneider B, Harbott J, Jager U, von Bergh AR, Loncarevic IF, Jarosova M, Schmidt HH, Moore SD, Marschalek R, Haas OA (2006) Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants. Genes Chromosomes Cancer 45(11):1041–1049. doi:10.1002/gcc.20372 PubMedCrossRef

69.

Licht JD, Chomienne C, Goy A, Chen A, Scott AA, Head DR, Michaux JL, Wu Y, DeBlasio A, Miller WH Jr et al (1995) Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood 85(4):1083–1094PubMed

70.

Mitani K, Kanda Y, Ogawa S, Tanaka T, Inazawa J, Yazaki Y, Hirai H (1995) Cloning of several species of MLL/MEN chimeric cDNAs in myeloid leukemia with t(11;19)(q23;p13.1) translocation. Blood 85(8):2017–2024PubMed

71.

Kakihana K, Kubo F, Wakabayashi S, Kurosu T, Miki T, Murakami N, Miura O (2008) A novel variant form of MLL-ELL fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia. Cancer Genet Cytogenet 184(2):109–112. doi:10.1016/j.cancergencyto.2008.04.001 PubMedCrossRef

72.

Uphoff CC, MacLeod RA, Denkmann SA, Golub TR, Borkhardt A, Janssen JW, Drexler HG (1997) Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines. Leukemia 11(3):441–447PubMedCrossRef

73.

Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA (1995) The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85(12):3662–3670PubMed

74.

Abdelhaleem M, Yi Q, Beimnet K, Hitzler J (2006) A novel TEL-AML1 fusion transcript involving the pro-apoptotic gene BCL-G in pediatric precursor B acute lymphoblastic leukemia. Leukemia 20(7):1294. doi:10.1038/sj.leu.2404249 PubMedCrossRef

75.

Park TS, Kim JS, Song J, Lee KA, Yoon S, Suh B, Lee JH, Lee HJ, Kim JK, Choi JR (2009) Acute promyelocytic leukemia with insertion of PML exon 7a and partial deletion of exon 3 of RARA: a novel variant transcript related to aggressive course and not detected with real-time polymerase chain reaction analysis. Cancer Genet Cytogenet 188(2):103–107. doi:10.1016/j.cancergencyto.2008.09.002 PubMedCrossRef

76.

Lim G, Cho EH, Cho SY, Shin SY, Park JC, Yang YJ, Oh SH, Marschalek R, Meyer C, Park TS (2011) A novel PML-ADAMTS17-RARA gene rearrangement in a patient with pregnancy-related acute promyelocytic leukemia. Leuk Res 35(7):e106–e110. doi:10.1016/j.leukres.2011.03.020 PubMedCrossRef

77.

Hiorns LR, Min T, Swansbury GJ, Zelent A, Dyer MJ, Catovsky D (1994) Interstitial insertion of retinoic acid receptor-alpha gene in acute promyelocytic leukemia with normal chromosomes 15 and 17. Blood 83(10):2946–2951PubMed

78.

Vizmanos JL, Larrrayoz MJ, Odero MD, Lasa R, Gonzalez M, Novo FJ, Calasanz MJ (2002) Two new molecular PML-RARalpha variants: implications for the molecular diagnosis of APL. Haematologica 87(8):ELT37PubMed

79.

Zayed A, Couban S, Hayne O, Sparavalo N, Shawwa A, Sadek I, Greer W (2007) Acute promyelocytic leukemia: a novel PML/RARalpha fusion that generates a frameshift in the RARalpha transcript and ATRA resistance. Leuk Lymphoma 48(3):489–496. doi:10.1080/10428190601136163 PubMedCrossRef

80.

Oh SJ, Park TS, Lee JY, Mun YC, Seong CM, Marschalek R, Meyer C, Chung WS, Huh J (2013) Acute promyelocytic leukemia with a rare PML exon 4/ RARA exon 3 fusion transcript variant. Acta Haematol 130(3):176–180. doi:10.1159/000348551 PubMedCrossRef

81.

Jeziskova I, Razga F, Gazdova J, Doubek M, Jurcek T, Koristek Z, Mayer J, Dvorakova D (2010) A case of a novel PML/RARA short fusion transcript with truncated transcription variant 2 of the RARA gene. Mol Diagn Ther 14(2):113–117. doi:10.2165/11317400-000000000-00000 PubMedCrossRef

82.

Kong XT, Ida K, Ichikawa H, Shimizu K, Ohki M, Maseki N, Kaneko Y, Sako M, Kobayashi Y, Tojou A, Miura I, Kakuda H, Funabiki T, Horibe K, Hamaguchi H, Akiyama Y, Bessho F, Yanagisawa M, Hayashi Y (1997) Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript. Blood 90(3):1192–1199PubMed

83.

Cocce MC, Alonso CN, Rossi J, Felice MS, Gitter MR, Gallego MS (2015) A case of pediatric ALL with t(16;21)(p11.2;q22) and FUS-ERG rearrangement. Blood Res 50(1):55–58. doi:10.5045/br.2015.50.1.55 PubMedPubMedCentralCrossRef

84.

Ichikawa H, Shimizu K, Hayashi Y, Ohki M (1994) An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res 54(11):2865–2868PubMed

85.

Jiang H, Qiu H, Xue Y, Pan J, Wu Y, Zhang J, Zheng J, Wang Q, Liang J, Chen S (2011) Establishment and characterization of a novel acute myeloid leukemia cell line, JIH-4, carrying a t(16;21)(p11.2;q22) and expressing the FUS-ERG fusion. Cancer Genet 204(4):219–223. doi:10.1016/j.cancergen.2011.02.005 PubMedCrossRef

86.

Takahashi H, Goto H, Eunabiki T, Fujii H, Yamazaki S, Fujioka K, Ikuta K, Kai S (2001) Expression of two types of E2A-HLF fusion proteins in YCUB-2, a novel cell line established from B-lineage leukemia with t(17;19). Leukemia 15(6):995–997PubMedCrossRef

87.

Hunger SP, Devaraj PE, Foroni L, Secker-Walker LM, Cleary ML (1994) Two types of genomic rearrangements create alternative E2A-HLF fusion proteins in t(17;19)-ALL. Blood 83(10):2970–2977PubMed

88.

Panagopoulos I, Micci F, Thorsen J, Haugom L, Tierens A, Ulvmoen A, Heim S (2012) A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13). Cancer Genet 205(12):669–672. doi:10.1016/j.cancergen.2012.10.004 PubMedCrossRef

89.

Pui C-H (2006) Childhood leukemias, 2nd edn. Cambridge University Press, CambridgeCrossRef

90.

Steinleitner K, Rampetsreiter P, Koffel R, Ramanathan G, Mannhalter C, Strobl H, Wieser R (2012) EVI1 and MDS1/EVI1 expression during primary human hematopoietic progenitor cell differentiation into various myeloid lineages. Anticancer Res 32(11):4883–4889PubMedPubMedCentral

91.

Kustikova OS, Schwarzer A, Stahlhut M, Brugman MH, Neumann T, Yang M, Li Z, Schambach A, Heinz N, Gerdes S, Roeder I, Ha TC, Steinemann D, Schlegelberger B, Baum C (2013) Activation of Evi1 inhibits cell cycle progression and differentiation of hematopoietic progenitor cells. Leukemia 27(5):1127–1138. doi:10.1038/leu.2012.355 PubMedCrossRef

92.

Barjesteh van Waalwijk van Doorn-Khosrovani S, Erpelinck C, van Putten WL, Valk PJ, van der Poel-van de Luytgaarde S, Hack R, Slater R, Smit EM, Beverloo HB, Verhoef G, Verdonck LF, Ossenkoppele GJ, Sonneveld P, de Greef GE, Lowenberg B, Delwel R (2003) High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood 101(3):837–845. doi:10.1182/blood-2002-05-1459 PubMedCrossRef

93.

Su G, Lian X, Tan D, Tao H, Liu H, Chen S, Yin H, Wu D, Yin B (2015) Aberrant expression of ecotropic viral integration site-1 in acute myeloid leukemia and acute lymphoblastic leukemia. Leuk Lymphoma 56(2):472–479. doi:10.3109/10428194.2014.924118 PubMedCrossRef

94.

Russell M, List A, Greenberg P, Woodward S, Glinsmann B, Parganas E, Ihle J, Taetle R (1994) Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Blood 84(4):1243–1248PubMed

95.

Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC, Behm FG, Pui CH, Downing JR, Gilliland DG, Lander ES, Golub TR, Look AT (2002) Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1(1):75–87PubMedCrossRef

96.

Hatano M, Roberts CW, Minden M, Crist WM, Korsmeyer SJ (1991) Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science 253(5015):79–82PubMedCrossRef

97.

O'Neil J, Look AT (2007) Mechanisms of transcription factor deregulation in lymphoid cell transformation. Oncogene 26(47):6838–6849. doi:10.1038/sj.onc.1210766 PubMedCrossRef

98.

Lichty BD, Ackland-Snow J, Noble L, Kamel-Reid S, Dube ID (1995) Dysregulation of HOX11 by chromosome translocations in T-cell acute lymphoblastic leukemia: a paradigm for homeobox gene involvement in human cancer. Leuk Lymphoma 16(3–4):209–215. doi:10.3109/10428199509049759 PubMedCrossRef

99.

Brake RL, Kees UR, Watt PM (2002) A complex containing PBX2 contributes to activation of the proto-oncogene HOX11. Biochem Biophys Res Commun 294(1):23–34. doi:10.1016/S0006-291X(02)00426-6 PubMedCrossRef

Titel: Molecular analysis of more than 140 gene fusion variants and aberrant activation of EVI1 and TLX1 in hematological malignancies
verfasst von: Faramarz Ghasemian Sorbeni
Soheila Montazersaheb
Atefeh Ansarin
Ali Esfahani
Azim Rezamand
Ebrahim Sakhinia
Publikationsdatum: 05.08.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Annals of Hematology / Ausgabe 10/2017
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-017-3075-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Molecular analysis of more than 140 gene fusion variants and aberrant activation of EVI1 and TLX1 in hematological malignancies

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2017

Awareness of tuberculosis among patients with newly diagnosed immune thrombocytopenia in the endemic area

Blastic plasmacytoid dendritic cell neoplasm: a pathological illustration of two clinical cases

Return to work and work-related disability among AML survivors

Cytogenetics with flow cytometry in lymph node/extranodal tissue biopsies is sensitive to assist the early diagnosis of suspected lymphomas

The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a review

GATA2 gene analysis in several forms of hematological malignancies including familial aggregations

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin